The DLBCL subgroup with PD-L1 is associated with a poor prognosis compared to the PD-1-negative subgroup (Laurent et al., 2015; Kiyasu et al., 2015). The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.